High blood pressure is a health problem that affects millions of people worldwide. It happens when blood pushes too hard against the walls of your arteries, much like cars speeding on a busy highway.
If this pressure stays high for too long, it can damage your heart, brain, and kidneys, increasing the risk of heart attacks, strokes, and kidney disease. Thankfully, doctors have many ways to manage high blood pressure, from lifestyle changes to medicines.
One type of medicine often given to people with high blood pressure is called a diuretic, or ‘water pill.’ These medicines help the body get rid of extra salt and water, which can lower blood pressure.
Two common diuretics are chlorthalidone and hydrochlorothiazide. Both have been used for many years and can be effective in preventing serious problems like heart attacks and strokes.
Researchers at Columbia University studied data from over 730,000 people who took blood pressure medicine over a period of 17 years. They wanted to compare chlorthalidone with hydrochlorothiazide to see how safe each one is.
They found that while both medicines work well for lowering blood pressure and protecting the heart, chlorthalidone may carry a higher risk of certain side effects.
The biggest difference they found was in potassium levels. Potassium is a mineral that helps your muscles and nerves work properly, including the muscles in your heart. People taking chlorthalidone were almost three times more likely to develop very low potassium levels, a condition called hypokalemia.
Low potassium can cause muscle weakness, tiredness, irregular heartbeats, and other health problems. In this study, 6.3% of people taking chlorthalidone had low potassium, compared to only 1.9% of those taking hydrochlorothiazide.
The researchers also noticed that people on chlorthalidone had more problems with their electrolytes—important minerals in the body that keep the heart beating steadily and muscles working well.
They also saw a higher risk of kidney problems among chlorthalidone users. The kidneys play a vital role in cleaning the blood and balancing body fluids, so any damage to them can be serious.
It’s important to remember that not everyone taking chlorthalidone will have these side effects. However, knowing about these risks means doctors can check potassium and kidney function more often in patients who take this medicine.
At the moment, many doctors prefer chlorthalidone over hydrochlorothiazide, but this research may encourage them to rethink their approach.
Managing blood pressure is about more than just medication. Eating plenty of fruits and vegetables, reducing salt, exercising regularly, limiting alcohol, and avoiding smoking all help keep blood pressure in a healthy range. Managing stress is also important—activities like yoga, meditation, walking, or listening to music can make a difference.
The researchers will continue to study these medicines to better understand their safety. If you or someone you know takes chlorthalidone, there’s no need to panic.
The best thing you can do is have regular check-ups with your doctor, report any changes in how you feel, and follow their advice. That way, you can help keep your blood ‘highways’ running smoothly for years to come.
If you care about blood pressure, please read studies about the arm squeeze test: could your blood pressure reading be wrong and bedtime medication more effective for high blood pressure.
For more information about blood pressure, please read studies about Scientists find link between high blood pressure drugs and this skin disease and common high blood pressure medication may not be the best choice.
If you care about blood pressure, please read studies about common blood pressure medication that may extend your healthy life span and common high blood pressure drug linked to sudden cardiac arrest.
For more information about blood pressure, please read studies that timing matters when taking high blood pressure pills and 1 in 5 people with high blood pressure taking a drug worsen the disease.
Copyright © 2025 Knowridge Science Report. All rights reserved.
